SonoTarg has developed a new approach to targeted cancer therapy that enables physicians to specifically activate therapeutics at the site of tumour and minimise the adverse effects associated with conventional chemotherapy.

The technology is based on research co-developed between the Universities of Ulster and Oxford and in close collaboration with leading clinicians at Belfast Hospitals.

Read more at www.sonotarg.com

Health Care

Life Sciences

SonoTarg Ltd

Org chart

Teams

Similar companies